@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-ND8GWGK4-G
  skos:prefLabel "Prednimustine"@fr, "Prednimustine"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:broader jvr:-FFMPZ4R2-J .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-RH7RGR6D-2
  skos:prefLabel "Antineoplastic Agents, Alkylating"@en, "Antinéoplasiques alcoylants"@fr ;
  a mesh:Descriptor, skos:Concept .

jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-R0ZCQ8X6-J
  skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-M63HSDM7-1
  skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-G4R176S9-J
  skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-WQXMZ66C-2
  skos:prefLabel "Moutardes à l'azote"@fr, "Nitrogen Mustard Compounds"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-FFMPZ4R2-J .

jvr:-FFMPZ4R2-J
  skos:narrower jvr:-ND8GWGK4-G ;
  skos:hiddenLabel "NSC3088"@fr, "Leukeran"@en, "Amboclorin"@en, "CB1348"@fr, "NSC-3088"@fr, "NSC-3088"@en, "CB-1348"@fr, "CB-1348"@en, "Lympholysin"@en ;
  skos:altLabel "Chloraminophene"@en, "305-03-3 (Chlorambucil)"@en, "305-03-3 (Chlorambucil)"@fr, "Chlorbutin"@en, "Benzenebutanoic acid, 4-(bis(2-chloroethyl)amino)-"@fr, "Benzenebutanoic acid, 4-(bis(2-chloroethyl)amino)-"@en, "N,N-Di-(2-chloroethyl)-p-aminophenylbutyric Acid"@en, "18D0SL7309"@fr, "18D0SL7309"@en, "4-(Bis(2-chloroethyl)amino)benzenebutanoic Acid"@en ;
  mesh:allowableQualifier jvr:-T9HQD7ST-J, jvr:-S0CS1X5R-5, jvr:-M63HSDM7-1, jvr:-L6C0XPHT-4, jvr:-NB0XHT3S-N, jvr:-TJHVZCRZ-0, jvr:-BT300B3G-Q, jvr:-Q3979798-W, jvr:-NHL3D2X0-S, jvr:-NFTHND7Q-8, jvr:-HQRFT0C6-B, jvr:-D0F21513-5, jvr:-R3QWLHRG-V, jvr:-WK5F724J-1, jvr:-XV06LPML-W, jvr:-R0ZCQ8X6-J, jvr:-SBNWSM1T-R, jvr:-NKM836P1-M, jvr:-H7K65Q8S-Z, jvr:-W6SQV79N-S, jvr:-G30ZJ446-J, jvr:-FWD2BGQ0-9, jvr:-G4R176S9-J, jvr:-THHNVC7V-3, jvr:-CB30NGKB-3 ;
  skos:definition "A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)"@en ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D002699> ;
  dc:created "1999-01-01"^^xsd:date ;
  dc:modified "2016-07-01"^^xsd:date ;
  skos:prefLabel "Chlorambucil"@en, "Chlorambucil"@fr ;
  skos:inScheme jvr: ;
  a skos:Concept, mesh:Descriptor ;
  mesh:pharmacologicalAction jvr:-RH7RGR6D-2 ;
  skos:broader jvr:-WQXMZ66C-2 ;
  dc:established "1966-01-01"^^xsd:date .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

